CD177 and autoimmune disease: In the case of patients with autoimmune diseases, treatments are based on drugs such as anti-TNF agents and interleukin-6 receptor blockers, thus favoring the onset of infections by blocking the signal transduction from the cell surface receptors to the nucleus [63].